.jpg)
.png)
Features
January 16, 2026
Dietary Patterns & Nutrition Interventions for Individuals with Dyslipidemia
The mission of the National Lipid Association (NLA) is “to enhance the science and practice of lipidology and promote...
Read More...December 15, 2025
U.S. Food and Drug Administration Approves LIB Therapeutics’ LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol
CINCINNATI, Ohio – December 15, 2025 – LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company...
Read More...October 6, 2025
Amgen Makes Repatha® Available Through AmgenNow, A Direct-to-patient Program in the US
THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch...
Read More...August 25, 2025
REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food...
Read More...June 20, 2025
National Lipid Association Releases New Guidance: “LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better”
The National Lipid Association (NLA) today announced the release of a major new clinical guidance document titled “LDL...
Read More...